Assessing the Impact of Pegylated-Interferon/Ribavirin Therapy Duration Versus Viral Response on Health-Related Quality of Life (Qol) Outcomes In Chronic Hepatitis C Virus (Hcv) Patients, Using Multivariate Mixed-Effects Modeling
Thilakarathne, P, Van Sanden, S, Diels, J, Mehnert, AVolume:
18
Language:
english
Journal:
Value in Health
DOI:
10.1016/j.jval.2015.03.1411
Date:
May, 2015
File:
PDF, 70 KB
english, 2015